Related Experiment Videos
Cholesterol treatment guidelines update
Richard S Safeer1, Prabha S Ugalat
1Concentra Medical Centers, Baltimore, Maryland, USA. shcs@starpower.net
American Family Physician
|March 20, 2002
Summary
New guidelines for managing high cholesterol emphasize aggressive treatment and risk assessment. They introduce "CHD equivalents" like diabetes for proactive heart disease prevention.
Area of Science:
- Cardiology
- Public Health
Background:
- Hypercholesterolemia is a primary driver of atherosclerosis and coronary heart disease.
- The National Cholesterol Education Program (NCEP) provides clinical guidelines for cholesterol management.
- The 2001 NCEP guidelines updated strategies from the 1993 report.
Purpose of the Study:
- To present the updated NCEP guidelines for hypercholesterolemia management.
- To highlight changes in risk assessment and therapeutic approaches.
- To introduce the concept of Coronary Heart Disease (CHD) equivalents.
Main Methods:
- Review and synthesis of the NCEP's third report on detection, evaluation, and treatment of high blood cholesterol in adults.
- Identification of key modifications in risk stratification and treatment goals.
- Definition and categorization of CHD equivalents.
Main Results:
- Modified risk assessment strategies incorporating factors like age, smoking, hypertension, HDL, and family history.
- Emphasis on a more aggressive therapeutic approach for hypercholesterolemia.
- Introduction of CHD equivalents: conditions like diabetes or high 10-year cardiac event risk requiring similar vigilance as existing CHD.
Conclusions:
- The updated guidelines advocate for aggressive management of hypercholesterolemia.
- Risk factors significantly influence low-density lipoprotein (LDL) goals.
- Post-LDL normalization, attention should shift to metabolic syndrome and hypertriglyceridemia.